BMRA
BIOMERICA INCstockNASDAQ
biomerica, inc. (www.biomerica.com) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. the company's products are designed to enhance health and well-being, while reducing total healthcare costs. biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. the biomerica infoods® ibs product identifies patient specific foods that when removed may alleviate an individual's ibs symptoms. this patent pending diagnostic guided therapy is designed to allow for a patient specific guided dietary regimen to improve irritable bowel syndrome (ibs) outcomes. the point-of-care product is being developed to allow physicians to perform the test in-office using a finger stick blood sample while a clinical lab version of the product will be the first for wh
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.30 | 2026-11-12 | -16.92% | -0.456 |
| 1M | 1.76 | 2026-10-19 | -38.64% | 1.109 |
| 3M | 1.52 | 2026-08-19 | -28.95% | 1.296 |
| 6M | 2.38 | 2026-05-19 | -54.62% | 0.825 |
| 1Y | 2.18 | 2025-11-19 | -50.46% | 0.799 |
| 2Y | 2.56 | 2024-11-19 | -57.80% | — |
| 5Y | 40.64 | 2021-11-19 | -97.34% | 0.815 |
BIOMERICA INC (NASDAQ:BMRA) stock price today is $1.08, and today's volume is 14,651. BMRA is down 12.551% today. The 30 day average volume is 10,773. BMRA market cap is $4.97M with 4.60M shares outstanding.
